| |||||||||||||
| Rating | Health Concerns |
|---|---|
![]() |
Liver cirrhosis (hepatic encephalopathy) (L-ornithine-L-aspartate) Recovery from illness (ornithine alpha-ketoglutarate) |
![]() |
Athletic performance (for body composition and strength) |
Reliable and relatively consistent scientific data showing a substantial health benefit. Contradictory, insufficient, or preliminary
studies suggesting a health benefit or minimal health benefit. For an herb, supported by traditional use but
minimal or no scientific evidence. For a supplement, little scientific support and/or minimal
health benefit. | |
Since ornithine is produced by the body, a deficiency of this nonessential amino acid is unlikely, though depletion can occur during growth or pregnancy, and after severe trauma or malnutrition.11
Most people would not benefit from ornithine supplementation. In human research involving ornithine, 5–10 grams are typically used per day, sometimes combined with arginine.
No side effects have been reported with the use of ornithine, except for gastrointestinal distress with intakes over 10 grams per day.
The presence of arginine is needed to produce ornithine in the body, so higher levels of this amino acid should increase ornithine production.
At the time of writing, there were no well-known drug interactions with ornithine.
1. Bucci LR, Hickson JF, Wolinsky I, Pivarnik JM. Ornithine supplementation and insulin release in bodybuilders. Int J Sport Nutr 1992;2:287–91.
2. Fogelholm GM, Naveri HK, Kiilavuori KT, et al. Low-dose amino acid supplementation: no effects on serum human growth hormone and insulin in male weightlifters. Int J Sport Nutr 1993;3:290–7.
3. Lambert MI, Hefer JA, Millar RP, et al. Failure of commercial oral amino acid supplements to increase serum growth hormone concentrations in male body-builders. Int J Sport Nutr 1993;3:298–305.
4. Bucci L, Hickson JF, Pivarnik JM, et al. Ornithine ingestion and growth hormone release in bodybuilders. Nutr Res 1990;10:239–45.
5. Elam RP, Hardin DH, Sutton RA, et al. Effects of arginine and ornithine on strength, lean body mass and urinary hydroxyproline in adult males. J Sports Med Phys Fitness 1989;29:52–6.
6. Cynober L. place des nouveaux substrats azotés en nutrition artificielle périopératoire de l’adulte. Nutr Clin Métabole 1995;9:113 [in French].
7. Brocker P, Vellas B, Albarede JL, Poynard T. A two-centre, randomized, double-blind trial of ornithine oxoglutarate in 194 elderly, ambulatory, convalescent subjects. Age Ageing 1994;23:303–6.
8. Stauch S, Kircheis G, Adler G, et al. Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study. J Hepatol 1998;28:856–64.
9. Cynober L. Amino acid metabolism in thermal burns. JPEN J Parenter Enteral Nutr 1989;13:196–205.
10. De Bandt JP, Coudray-Lucas C, Lioret N, et al. A randomized controlled trial of the influence of the mode of enteral ornithine alpha-ketoglutarate administration in burn patients. J Nutr 1998;128:563–9.
11. Zieve L. Conditional deficiencies of ornithine or arginine. J Am Coll Nutr 1986;5:167–76. [review]
| |||||||